Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia

NCT06056570 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Hyperuricemia

Interventions

DRUG: dontinurad
DRUG: dotinurad + allopurinol
DRUG: allopurinol

Sponsor

Urica Therapeutics Inc.